A new device analyzes pill dissolution rates to generate digital fingerprints that distinguish real from counterfeit drugs. The approach offers a low-cost solution to enhance drug quality monitoring.
ABC7: With FDA approval of Wegovy pill, new era of oral GLP-1 weight loss drugs begins
The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk's weight-loss drug Wegovy, introducing a new option for how patients can take medicines in a class of drugs ...
With FDA approval of Wegovy pill, new era of oral GLP-1 weight loss drugs begins
MSN: Eli Lilly Has Seized the Lead in Anti-Obesity Drugs. Next Up: a Pill.
Eli Lilly Has Seized the Lead in Anti-Obesity Drugs. Next Up: a Pill.
The use of psychoactive drugs without medical supervision is associated with significant health risks and can lead to the development of drug use disorders. Drug use disorders, particularly when untreated, increase morbidity and mortality risks for individuals, can trigger substantial suffering and lead to impairment in personal, family, social, educational, occupational or other important ...
The Unit works globally to improve health and well-being of populations by articulating, promoting, supporting and monitoring evidence-informed policies, strategies and interventions to reduce the burden associated with alcohol, drugs and addictive behaviours.
Publications of the World Health Organization Home / Publications / Overview / Canada: A List of Essential Prescription Drugs and Related Products-Initial Recommendation 2025 (English)
This report presents the first World Health Organization (WHO) analysis of antifungal agents in preclinical and clinical development. It covers systemic antifungal drugs in development worldwide, including label extension and repurposed products, and critically evaluates how well the current pipeline addresses infections caused by WHO fungal priority pathogens.